Interview with Geoffrey Rose, M.D., president of Sanger Heart and Vascular Institute with Atrium Health, in Charlotte, North Carolina, and a board member with the American Society of Echocardiography (ASE). He explains the impact of COVID-19 (SARS-CoV-2) on the cardiovascular service line and cardiac imaging. He said the virus has led to use of computed tomography (CT) not only as the frontline cardiovascular imaging modality to evaluate chest pain, but also for COVID-19 pneumonia imaging.
Rose said cardiac ultrasound is still used, but requires full personal protective equipment (PPE) and often abbreviated exams because of the close proximity of the sonographer and patient when performing echocardiograms. This has given rise to using dedicated point-of-care ultrasound (POCUS) systems to answer specific clinical questions quickly. Smart-phone based POCUS systems that use an app and a transducer plugged into the phone enable basic echo exams or evaluation of other parts of the anatomy quickly without the need to immediately sterilize an entire cart-based ultrasound system. These small systems also can be completely enclosed inside a transducer sheath and the phone and single transducer are much easier and faster to wipe down. He said the quality of the exams are not as good as fully enabled echocardiography systems, but it allows for quick assessments of ejection fractions and to triage if the patient needs more advanced imaging if the basic questions cannot be answered.
Since hospitals have shut down now for about two months, postponing normal checkups, and elective exams and procedures, Rose said doctors still need to visit with patients who have chronic conditions. Sanger and Atrium Heath modified its ambulatory electronic medical record (EMR) and is using video conferencing to perform virtual appointments now for the majority of these patients. He said telemedicine was not widely used before COVID-19 in his hospital system, but the pandemic will likely alter the care model for the future, with more telemedicine visits being used even after epidemic is over. He said use of POCUS and CT as frontline cardiac imaging modalities will also likely remain in place after the pandemic because of the efficiencies in care these technologies offer.
Related Coronavirus Content:
VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)
Cardiac Imaging Best Practices During the COVID-19 Pandemic
RSNA Publishes COVID-19 Best Practices for Radiology Departments
ASE Guidelines for the Protection of Echocardiography Providers During the COVID-19 Outbreak
New CT Scoring Criteria for Timely Diagnosis, Treatment of Coronavirus Disease
FDA Issues New Policy for Imaging Systems During COVID-19
VIDEO: COVID-19 Precautions for Cardiac Imaging — Interview with Stephen Bloom, M.D.
A Review of Studies Cautions Against Chest CT for Coronavirus Diagnosis
New Research Finds Chest X-ray Not Reliable Diagnostic Tool for COVID-19
VIDEO: Radiology Industry Responding to COVID-19
University of Washington Issues Radiology Policies for COVID-19
VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic — Interview with Hicham Skali, M.D.
New Research Highlights Blood Clot Dangers of COVID-19
Survey Reveals Most Medical Practices are Now Using Telehealth Due to COVID-19
CMS Offers Recommendations on Reopening Healthcare in Areas of Low COVID-19 Cases
CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)
Radiology Lessons for Coronavirus From the SARS and MERS Epidemics
Radiologists Describe Coronavirus CT Imaging Features
CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia
ACC COVID-19 recommendations for the cardiovascular care team
VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.
The Cardiac Implications of Novel Coronavirus
1498 Views
Recent Videos View all 644 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Sponsored Videos View all 46 items
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.
Watch the video to check out how TrueVue can help improve views of LAA and MV morphology.
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*
Watch the video to see how you can put “smart” to work with the latest AI-powered quantification tools.
*External study with external sonographers comparing the results of 18 exams with and without AutoMeasure
The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer.
Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more.
Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.
Conference Coverage View all 460 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cath Lab View all 316 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Imaging View all 287 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Diagnostics View all 78 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
EP Lab View all 83 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Information Technology View all 169 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)